# Efficacy and Safety of Sub-tenon Ranibizumab for Recurrent Pterygia

> **NCT01169909** · PHASE1 · COMPLETED · sponsor: **University of New Mexico** · enrollment: 10 (actual)

## Conditions studied

- Pterygium

## Interventions

- **DRUG:** Ranibizumab

## Key facts

- **NCT ID:** NCT01169909
- **Lead sponsor:** University of New Mexico
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-08
- **Primary completion:** 2014-07
- **Final completion:** 2014-07
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2016-05-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01169909

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01169909, "Efficacy and Safety of Sub-tenon Ranibizumab for Recurrent Pterygia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01169909. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*